Who determines value in a clinical service

While a patient may seek healing and a physician may offer expertise, the actual dollar value of a clinical service in modern healthcare is largely determined by a secretive committee of 31 doctors meeting behind closed doors. This group, the American Medical Association’s [Specialty Society Relative Value Update Committee](https://en.wikipedia.org/wiki/Specialty_Society_Relative_Value_Update_Committee) (RUC), wields immense power over the American healthcare economy by advising Medicare on how to price physician work. Determining value in a clinical service is not a unified calculation but a structural tension between three distinct, competing arbiters: the technocratic pricing state, the experiencing patient, and the clinical trialist. ## The Technocratic State and Resource-Based Value At the systemic level, value is determined through rigorous microeconomic modeling of resource consumption. Following the landmark work of William Hsiao and his colleagues in *A National Study of Resource-Based Relative Values for Physician Services*, published in the [New England Journal of Medicine](https://www.nejm.org/doi/full/10.1056/NEJM198810283191730), value is conceptualized as a function of work, practice expense, and malpractice insurance. This objective, input-based valuation translates clinical labor into Relative Value Units (RVUs). However, this technocratic approach often creates a distortion where procedural interventions are highly valued while cognitive care, such as chronic disease counseling, is undervalued. ## The Patient and Phenomenological Value In contrast to objective RVUs, patients determine value through the lens of subjective utility, functional recovery, and dignity. Michael Porter of Harvard Business School revolutionized this perspective in [What Is Value in Health Care?](https://www.nejm.org/doi/full/10.1056/NEJMp1011024), where he argued that value must be defined as the health outcomes achieved per dollar spent. > "Value in health care is measured by the outcomes achieved, not the volume of services delivered, and eliminating duplication, unnecessary interventions, and administrative complexity is the only true way to bend the cost curve." From the patient's viewpoint, a highly complex clinical service that does not improve quality of life or reduce suffering holds zero, or even negative, value. ## The Evidence-Based Consensus Finally, the scientific community determines clinical value by evaluating comparative effectiveness. Through institutions like the [National Institute for Health and Care Excellence](https://www.nice.org.uk/) (NICE) in the United Kingdom, value is calculated using the Quality-Adjusted Life Year (QALY). Here, clinical value is not a matter of subjective satisfaction or physician effort, but a mathematical proof of incremental cost-effectiveness ratios. Ultimately, clinical value is never determined by a single entity. It is a constantly shifting compromise negotiated between the state's accounting books, the patient's lived experience, and the clinical trial's statistical power. ## Follow-up questions 1. How do cognitive biases, such as the sunk cost fallacy, distort how both patients and physicians personally calculate the value of a failing clinical intervention? 2. To what extent does the reliance on Quality-Adjusted Life Years (QALYs) by health technology assessment bodies systematically undervalue treatments for rare diseases? 3. How will the integration of artificial intelligence in clinical decision-making shift the division of labor and the subsequent RVU-based valuation of physician work?